Compounds > reserpine
Page last updated: 2024-08-17

reserpine and pregabalin

reserpine has been researched along with pregabalin in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Castro, CJ; da Costa Lopes, AM; da Silva, CA; da Silva, JF; de Souza, AH; Ferreira, J; Gomez, MV; Klein, CP; Pereira, EM1
Alfosea-Cuadrado, GM; Blasco-Serra, A; Gonzalez-Soler, EM; Igual-Lopez, M; Orduna-Valls, J; Tornero-Tornero, C; Valverde-Navarro, AA1
Álvarez-Pérez, B; Boadas-Vaello, P; Deulofeu, M; Homs, J; Merlos, M; Vela, JM; Verdú, E1
Álvarez-Pérez, B; Bagó-Mas, A; Boadas-Vaello, P; Deulofeu, M; Merlos, M; Vela, JM; Verdú, E1

Reviews

1 review(s) available for reserpine and pregabalin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

5 other study(ies) available for reserpine and pregabalin

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
The effects of Phα1β, a spider toxin, calcium channel blocker, in a mouse fibromyalgia model.
    Toxicon : official journal of the International Society on Toxinology, 2014, Volume: 81

    Topics: Animals; Brain; Calcium Channel Blockers; Diclofenac; Disease Models, Animal; Dopamine; Fibromyalgia; gamma-Aminobutyric Acid; Hyperalgesia; Male; Mice; Pain; Pregabalin; Reserpine; Serotonin; Spider Venoms; Spiders

2014
Chronic Pregabalin Treatment Ameliorates Pain, but not Depressive-Like Behaviors, in a Reserpine-Induced Myalgia Model in Rats.
    Pain physician, 2020, Volume: 23, Issue:6

    Topics: Animals; Anticonvulsants; Antihypertensive Agents; Chronic Pain; Depression; Disease Models, Animal; Drug Administration Schedule; Male; Myalgia; Pain Threshold; Pregabalin; Random Allocation; Rats; Rats, Sprague-Dawley; Reserpine; Treatment Outcome

2020
Long-lasting reflexive and nonreflexive pain responses in two mouse models of fibromyalgia-like condition.
    Scientific reports, 2022, 06-12, Volume: 12, Issue:1

    Topics: Animals; Chronic Pain; Disease Models, Animal; Fibromyalgia; Mice; Pregabalin; Reserpine

2022
Long-Lasting Nociplastic Pain Modulation by Repeated Administration of Sigma-1 Receptor Antagonist BD1063 in Fibromyalgia-like Mouse Models.
    International journal of molecular sciences, 2022, Oct-08, Volume: 23, Issue:19

    Topics: Analgesics; Animals; Chronic Pain; Disease Models, Animal; Female; Fibromyalgia; Gliosis; Hyperalgesia; Mice; Mice, Inbred ICR; Pregabalin; Receptors, sigma; Reserpine; Sigma-1 Receptor

2022